Prosight Management, LP Quant / Systematic

Location: Dallas, TX

CIK: 0001617201 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 14, 2021

Total Value: $122M (100.0% shares, 0.0% debt)

Holdings (37)

PRTA PROTHENA CORP PLC 12.3%
Value $15.07M Shares 600,000 Est. Cost $11.93 Unrealized +57.7%
VRTX VERTEX PHARMACEUTICALS INC 6.7%
Value $8.241M Shares 38,350 Est. Cost $227.03 Unrealized -3.3%
EHC ENCOMPASS HEALTH CORP 6.7%
Value $8.19M Shares 100,000 Est. Cost $50.24 Unrealized +23.0%
ARENA PHARMACEUTICALS INC 6.0%
Value $7.343M Shares 105,828 Est. Cost $43.41 Unrealized
CUE CUE BIOPHARMA INC 5.6%
Value $6.793M Shares 556,777 Est. Cost $16.40 Unrealized -16.4%
BMY BRISTOL-MYERS SQUIBB CO 4.9%
Value $6.035M Shares 95,600 Est. Cost $48.17 Unrealized +5.9%
ALBIREO PHARMA INC 4.9%
Value $6.005M Shares 170,352 Est. Cost $29.64 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 4.6%
Value $5.625M Shares 473,446 Est. Cost $6.60 Unrealized +74.4%
GLPG GALAPAGOS NV 4.2%
Value $5.12M Shares 66,419 Est. Cost $77.09 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 3.8%
Value $4.685M Shares 360,834 Est. Cost $14.72 Unrealized -1.4%
KEZAR LIFE SCIENCES INC 3.7%
Value $4.472M Shares 750,310 Est. Cost $5.96 Unrealized
MGTX MEIRAGTX HLDGS PLC 3.4%
Value $4.213M Shares 291,944 Est. Cost $20.76 Unrealized -24.8%
ZOGENIX INC 3.1%
Value $3.806M Shares 195,000 Est. Cost $22.52 Unrealized
ZBH ZIMMER BIOMET HOLDINGS INC 2.8%
Value $3.393M Shares 21,197 Est. Cost $110.07 Unrealized +35.1%
PRQR PROQR THRAPEUTICS N V 2.4%
Value $2.976M Shares 450,165 Est. Cost $4.61 Unrealized +11.0%
OSCR OSCAR HEALTH INC 2.4%
Value $2.878M Shares 107,086 Est. Cost $31.30 Unrealized 0.0%
CLLS CELLECTIS S A 2.3%
Value $2.787M Shares 137,900 Est. Cost $20.21 Unrealized
INOVALON HLDGS INC 2.0%
Value $2.446M Shares 85,000 Est. Cost $18.17 Unrealized
MDT MEDTRONIC PLC 1.9%
Value $2.373M Shares 20,088 Est. Cost $101.70 Unrealized 0.0%
UNH UNITEDHEALTH GROUP INC 1.8%
Value $2.232M Shares 6,000 Est. Cost $319.66 Unrealized 0.0%
CARA THERAPEUTICS INC 1.8%
Value $2.171M Shares 100,000 Est. Cost $14.99 Unrealized
METACRINE INC 1.5%
Value $1.888M Shares 304,485 Est. Cost $10.02 Unrealized
SOLID BIOSCIENCES INC 1.4%
Value $1.77M Shares 320,100 Est. Cost $5.53 Unrealized
LHC GROUP INC 1.4%
Value $1.679M Shares 8,783 Est. Cost $198.12 Unrealized
AKUMIN INC 1.3%
Value $1.588M Shares 429,061 Est. Cost $3.34 Unrealized
BEAM BEAM THERAPEUTICS INC 1.1%
Value $1.361M Shares 17,000 Est. Cost $95.13 Unrealized 0.0%
ALEXION PHARMACEUTICALS INC 1.1%
Value $1.328M Shares 8,685 Est. Cost $116.07 Unrealized
ONCORUS INC 0.8%
Value $986K Shares 70,807 Est. Cost $13.93 Unrealized
APTOSE BIOSCIENCES INC 0.7%
Value $896K Shares 150,000 Est. Cost $6.21 Unrealized
ADMA ADMA BIOLOGICS INC 0.7%
Value $876K Shares 497,842 Est. Cost $2.91 Unrealized -21.3%
EXICURE INC 0.5%
Value $601K Shares 275,848 Est. Cost $2.18 Unrealized
SIO GENE THERAPIES INC 0.4%
Value $537K Shares 205,900 Est. Cost $2.61 Unrealized
BAX BAXTER INTL INC 0.4%
Value $489K Shares 5,800 Est. Cost $76.07 Unrealized -6.1%
ODONATE THERAPEUTICS INC 0.3%
Value $402K Shares 117,621 Est. Cost $3.42 Unrealized
MORPHIC HLDG INC 0.3%
Value $329K Shares 5,202 Est. Cost $63.24 Unrealized
ORGO ORGANOGENESIS HLDGS INC 0.2%
Value $278K Shares 15,232 Est. Cost $5.07 Unrealized +167.2%
ASSEMBLY BIOSCIENCES INC 0.2%
Value $260K Shares 56,500 Est. Cost $4.60 Unrealized